About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...
Colorectal cancer continues to be a significant health concern in Canada. In 2024, it was the fourth most commonly diagnosed cancer in the country, and it's rising sharply among young and middle ...